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ABSTRACT
High-grade transitional cell carcinomas (TCCs) of the urinary bladder
are frequently associated with carcinoma in situ, which may replace large
areas of the mucosa of the urinary tract. The invasive component of TCCs
often reveals a loss of expression of the cell-cell adhesion molecule E-
cadherin, but the role of E-cadherin in the development and expansion of
intraepithelial neoplasia is unknown. To study the underlying mechanism
of intraepithelial expansion (IEE), we have developed an IEE assay.
Human TCC cell lines were investigated in this IEE assay for their
capacity to replace the surrounding normal murine urothelial cells. In
vitro IEE appeared to be prominent in three (SD, RT112, and 1207) of the
four E-cadherin-positive cell lines. Although the two E-cadherin-negative
cell lines (T24 and J82) were able to penetrate surrounding normal
urothelium as single cells, they largely lacked the capacity of IEE. These
results prompted us to investigate whether the cell-cell adhesion molecule
E-cadherin is an important determinant for IEE. T24 cells that were
transfected with full-length mouse E-cadherin cDNA displayed an en-
hanced IEE rate. Transfection did not influence their proliferative capac-
ity, their pattern and level of integrin expression, or their ability to expand
in the absence of surrounding urothelium. The data suggest that E-
cadherin-mediated cohesiveness is an important factor in the IEE of
bladder carcinoma cells. These observations argue for a dual, paradoxical
role of E-cadherin in bladder tumorigenesis. On the one hand, E-cadherin
promotes the expansion of intraepithelial neoplasia; on the other hand, its
loss correlates with invasive behavior.
INTRODUCTION
High-grade TCCs2 of the urinary tract are frequently accompanied
by carcinoma in situ (1). Carcinoma in situ of the urinary tract is
characterized by the replacement of the normal lining urothelium by
dysplastic cells, which show a variety of cellular and molecular
changes. Carcinoma in situ may replace large areas of the urinary tract
mucosa, extending even to the urethra and, in males, to the prostatic
ducts and glands (2). In general, carcinoma in situ is regarded as a
precursor lesion for invasive bladder carcinoma (3).
Patients with carcinoma in situ in the flat peripheral urothelium
adjacent to tumors have a higher probability of tumor recurrences
and/or invasion (4, 5). Clinical and experimental data suggest that
bladder tumor recurrences could be the consequence of an IEE of the
transformed cells from the original tumor or shedding and subsequent
reattachment of bladder cells, particularly to traumatized areas in the
bladder mucosa (6–11). Lateral expansion of the attached tumor cells
can then lead to the replacement of normal urothelium by cancer cells.
The mechanisms involved in lateral (i.e., intraepithelial) expansion of
bladder tumor cells are only partially understood. A cocultivation
model established recently in our laboratory permits the direct visu-
alization of attachment and subsequent IEE of bladder tumor cells at
the expense of surrounding normal urothelium (10, 11). In this assay,
a tumor cell suspension is inoculated on confluent mouse urothelial
cultures containing de-epithelialized areas of a standard size. Implan-
tation of tumor cells occurs predominantly in these de-epithelialized
areas, and the time course of IEE can be assessed by selective
immunostaining of the tumor cells. Previously, we have shown in this
model that exposure to growth factors and culture on substrates coated
with particular extracellular matrix proteins could influence IEE
(10, 11).
E-cadherin is a member of a family of transmembrane glycopro-
teins involved in intercellular adhesion. E-cadherin function is medi-
ated by the interaction with the cytoplasmatic a-, b-, and g-catenins.
These catenins connect E-cadherin with the cytoskeleton. In model
systems, loss of E-cadherin expression is associated with the gain of
the invasive phenotype in tumors (12, 13, 14). Similarly, it was
reported that loss of the invasion suppressor molecule E-cadherin or
catenins is associated with deeply invasive bladder cancer and is
predictive for poor survival of patients with bladder cancer (15–17).
The E-cadherin/catenin complex also contributes to a variety of phys-
iological functions like cell growth, differentiation, wound healing,
cell motility, morphogenesis, and organogenesis (18). However, its
role in the expansion of carcinoma in situ of the bladder has not yet
been studied.
In this study, initial experiments comparing E-cadherin-positive
and -negative human TCC cell lines suggested a potentially enhancing
role of E-cadherin in IEE. By use of T24 cells, stably transfected with
an E-cadherin cDNA construct, we could confirm that this molecule
indeed contributes to IEE, most likely by conveying increased cohe-
siveness to the TCC cells.
MATERIALS AND METHODS
Cell Culture. The human bladder cancer cell lines T24, SD, RT112, JON,
and J82 were kindly provided by Dr. J. A. Schalken (Urological Research
Laboratory, University Hospital Nijmegen, the Netherlands) and have been
characterized previously (19, 20). Human bladder carcinoma cell line 1207
was obtained from Dr. W. I. De Boer (GETU Service d’Urologie, Paris,
France; Ref. 21). Cell lines were maintained in the same standard medium as
the primary bladder explant cultures.
Primary Explant Cultures of Murine Urothelium. Murine urinary blad-
ders were dissected from female C3H/He mice, 6–8- weeks of age, and cut
into halves. The mucosa of the bladder was stripped from its underlying muscle
layer and subsequently spread on a collagen type IV (25 mg/ml human collagen
type IV)-coated Cyclopore membrane (Becton Dickinson Labware, Bedford,
MA) with the submucosa facing the culture support. Standard culture medium
consisted of a 1:1 mixture of DMEM and Ham’s F10, supplemented with 10%
heat-inactivated FCS, 10 mg/ml insulin, 5 mg/ml transferrin, 5 ng/ml selenite,
10 mM HEPES, 50 nM hydrocortisone, 100 IU/ml penicillin, and 100 mg/ml
streptomycin. The explant cultures were grown at 37°C in a humidified
atmosphere of 5% CO2. These murine explant cultures on porous membranes
mimic the in vivo situation; the cultured urothelium shows a polarized multi-
layering and differentiation into umbrella cells (22).
IEE Assay. The cocultivation model to study IEE of bladder carcinoma
cells was described previously (11). Briefly, in confluent murine explant
cultures, four standardized circular areas were denuded in the periphery of the
primary cultures by cautious imprinting with a 3-mm diameter biopsy punch
(Stiefel, Offenbach am Main, Germany). The urothelium in the injured areas
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was scraped away from the Cyclopore membrane with a micropipette tip.
Subsequently, the cultures were washed twice with PBS, followed by seeding
of 105 tumor cells in 1.5-ml standard medium on the murine urothelial explant
cultures. The bladder tumor cells were allowed to attach to the injured areas in
the explant cultures for 24 h; nonadherent cells were then washed away with
PBS, and the cultures were either terminated or continued for another 4, 7, or
14 days in standard medium. Each experiment was performed twice in tripli-
cate. The cultures were terminated by fixing them in 70% ethanol and stored
at 4°C until immunohistochemistry; selective identification of the human
bladder carcinoma cells was performed.
Monoclonal, human-specific antibodies, RCK108 (Eurodiagnostica, Arn-
hem, the Netherlands) or DC10 (Beckman Coulter, Fullerton, CA), directed
against cytokeratin 19 were used to distinguish the human bladder carcinoma
cells from murine urothelium (10). Monoclonal antibody DC10 was used for
staining J82 cells, whereas the other cell lines were stained with monoclonal
antibody RCK108. Nearly 100% of the bladder carcinoma cells of each cell
line was labeled with RCK108 or DC10. The secondary antibody was horse-
radish peroxidase-conjugated goat antimouse immunoglobulins (Dako,
Glostrup, Denmark). Peroxidase activity was visualized with 0.03% H2O2 and
0.02% 3,3,-diaminobenzidine tetrahydrochloride (Fluka, Basel, Switzerland)
diluted in PBS.
The immunostained areas were quantitated with a Hitachi CCTV camera
equipped with the KS400 image analysis software package (Kontron Elek-
tronik, Eching, Germany) and expressed in mm2.
Construction of Stable Transfectants. The E-cadherin-negative cell line
T24 was cotransfected with plasmids pBATEM2 and pSVneo, which harbors
the neomycin resistance gene. Marion Bussemakers (Urological Research
Laboratory, University Hospital Nijmegen) generously provided plasmid
pBATEM2, containing the full-length mouse E-cadherin cDNA, originally
constructed by Nagafuchi et al. (23). For transfection, cultures were cotrans-
fected with a total of 20 mg of DNA (pBATEM2:pSVneo, 20:1) using the
DNA-calcium phosphate method (24), and transfected cells were selected with
800 mg/ml G418. E-cadherin expression in these transfected cell lines was
detected as follows. Clones were grown to confluence on multichamber slides
(Nunc, Naperville, IL) and fixed in methanol at 220°C. Cells were incubated
overnight at 4°C with monoclonal antibody DECMA-1 (Sigma Chemical Co.,
Fig. 1. Low-power overviews of human bladder carcinoma cells adjacent to primary
normal mouse urothelium: A, T24 cells; and B, RT112 cells. Bladder carcinoma cells were
selectively stained with RCK108. Bar, 100 mm. U, unstained normal surrounding mouse
urothelium.
Fig. 2. IEE of six different bladder tumor cell lines. Graphs
display the area (mm2) occupied by human bladder tumor cells in
peripheral lesions measured on different time points. Data are ex-
pressed as means (n 5 six cultures, with four peripheral lesions
each); bars, SD. Note the difference in the scale of the Y axis in the
various graphs.
178
E-CADHERIN PROMOTES IEE
St. Louis, MO), followed by a biotinylated rabbit antirat immunoglobulins
(Dako) and fluorescein-conjugated streptavidin (Dako). The different clones
retained their resistance to G418 and were stable in their E-cadherin expression
during the entire course of the described experiments.
Flow Cytometric Analysis of E-Cadherin and Integrin Expression.
Cells were harvested by a short trypsinization of confluent monolayers. Cell
suspensions were made in PBS containing 0.5% BSA, 0.1% NaN3, 1 mM
CaCl2, and 0.5 mM MgCl2 at a concentration of 1 3 106 cells/ml. E-cadherin
expression of a selection of nine different, transfected T24 clones was exam-
ined with the DECMA-1 antibody, followed by biotinylated rabbit antirat
immunoglobulins and fluorescein-conjugated streptavidin. Integrin expression
was studied with the use of specific antibodies against a1-integrin (HP2B6;
Beckman Coulter, Fullerton, CA), a2-integrin (NCL-CDW49b; Novacastra,
Newcastle upon Tyne, United Kingdom), a3-integrin (NCL-CDW49c; Nova-
castra), a4-integrin (P4G9; Dako), a5-integrin (P1D6; Dako), a6-integrin
(NCL-CDW49f; Novacastra), b1-integrin (TDM29; Sanbio, Uden, the Neth-
erlands), and b3-integrin (NCL-CD61; Novacastra). As a negative control, the
primary antibody was omitted and replaced by a PBS/BSA/azide solution. Data
acquisition and analysis were performed on duplicate samples on a FACScan
flow cytometer using CELLQuest software (Becton Dickinson, San Jose, CA).
Immunoblotting. Confluent cultures were lysed in 23 sampling buffer
[4% SDS, 200 mM DTT, 100 mM Tris (pH 6.8), 20% glycerol, and 2% Triton
X-100], and equal quantities of protein (30 mg) were run on a 7.5% SDS-
PAGE. The MDCK cell line was used as a positive control for E-cadherin
expression. After electroblotting, blots were immunostained with the
DECMA-1 antibody, followed by biotinylated rabbit antirat immunoglobulins.
Next, an alkaline phosphatase-conjugated streptavidin label (Biogenex, San
Ramon, CA) was applied. Finally, bound antibody was visualized by histo-
chemical staining with nitro blue tetrazolium chloride/5-bromo-4-chloro-3-
indolyl phosphate toluidine salt (Roche Diagnostics, Basel, Switzerland).
In Vitro Invasion Assay. Chicken heart invasion assays were performed as
described by Mareel et al. (26). Briefly, a selection of E-cadherin-transfected
T24 clones was confronted with precultured rounded fragments of embryonic
chicken heart on soft agar for 24 h. Next, fragments with attached bladder
tumor cells were kept in suspension culture under gyrotory shaking (120 rpm;
37°C; 5% CO2) for 6 days in MEM REGA 3 medium (Life Technologies, Inc.,
Breda, the Netherlands) containing 10% FCS. Fragments were fixed in 4%
phosphate buffered formalin and embedded in paraffin. Invasion was scored on
serial histological sections stained with H&E. The tumor cells were distin-
guished from the heart tissue by their morphological features.
Wound Colonization Assay. T24 Clones were grown to confluence in
10-cm diameter culture dishes. With a plastic pipette tip, cells were scraped
away in the shape of a cross. The width of the lesion was ;5 mm. After 16 h,
the movement of cells into the wound was monitored and photographed.
Expansion of T24 Clones on Collagen Type IV-coated Cyclopore Mem-
branes. With a 3-mm diameter biopsy punch (Stiefel, Offenbach am Main,
Germany), a superficial circular imprint was made on the cell culture inserts,
coated with collagen type IV. A cell suspension of 105 cells/2 ml of standard
medium was pipetted within the borders of the circular imprint with a 10-ml
micropipette. The cells in the drop of medium attached into the circular area
within 24 h. Every 2 days, medium on top of the membranes was refreshed,
taking care that the medium only covered the area of tumor cells. Medium
underneath the membrane was refreshed twice a week. The circumferences of
the outgrowing sheet of tumor cells were drawn daily. From these drawings,
the area (mm2) of outgrowth was determined.
[3H]Thymidine Incorporation. To assess the potential differences in pro-
liferation of the different T24 clones, a cell kinetic study was performed as
described earlier (11). Briefly, T24 clones grown in 75-cm2 culture flasks were
synchronized in serum-free culture medium for 24 h. Subsequently, 105
cells/were seeded in collagen type IV-coated 96-well dishes and were cultured
in standard medium for 4 consecutive days. Proliferative activity was deter-
mined at 24, 48, 72, and 96 h. During the final 16 h of culture, cells were
incubated with 0.5 mCi of [3H]thymidine/well. The incorporated [3H]thymi-
dine in harvested cells was counted in a BetaPlate scintillation counter (LKB-
Pharmacia, Woerden, the Netherlands).
RESULTS
IEE of Human Bladder Carcinoma Cells. The IEE of a panel of
six different TCC cell lines was studied. After the seeding of tumor
cells on wounded confluent murine urothelial cultures, the tumor cells
preferentially attached to the de-epithelialized areas. Within 24 h,
these areas were covered both by tumor cells and regenerating urothe-
lium. Control experiments showed that in the absence of inoculated
tumor cells, the de-epithelialized areas became entirely covered by
regenerating normal urothelial cells within 24 h (11). The areas
covered by tumor cells at 24 h were of the same size for four of the
Fig. 3. Analysis of E-cadherin expression in transfected T24 clones. A, immunofluo-
rescent staining for E-cadherin in T24D1011 (3100). B, Western blotting of total lysates
of MDCK, T24, and T24 transfectants.
Table 1 Characteristics of bladder carcinoma cell lines
TCC cell lines were tested in an in vitro model of IEE. IEE was characterized by tumor
expansion (tumor area in mm2) and by the pattern that TCC cell lines displayed during
infiltration of the normal surrounding urothelium.
Cell line
E-cadherin
expression
(in vitro)
IEE
Tumor
expansion Infiltration pattern
SD 1 11 Sharp demarcation
T24 2 2/1 Single cells
RT112 1 1 Sharp demarcation
J82 2 2 Single cells
JON 1 2/1 Sharp demarcation
1207 2/1 1 Single cells
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six examined tumor cell lines, but implantation of JON or J82 cells
was less effective. As described previously, E-cadherin expression
influenced the pattern of IEE (10, 11). Bladder tumor cell lines with
no (T24 and J82) or a heterogeneous (1207) expression of E-cadherin
were able to infiltrate the surrounding normal urothelium as single
cells (Fig. 1A), whereas bladder tumor cell lines with a homogeneous
(SD, RT112, and JON) expression of E-cadherin displayed a sharp
demarcation between the tumor cells and the normal urothelium (Fig.
1B). The six tumor cell lines further differed with respect to their
subsequent IEE rate (Fig. 2 and Table 1). The IEE of bladder carci-
noma cells was most pronounced for the SD cells and less for the 1207
and RT112 cells, whereas T24, JON, or J82 displayed hardly any or
no expansion. Therefore, three of four E-cadherin-positive bladder
carcinoma cell lines had a better IEE rate than the two E-cadherin-
negative bladder carcinoma cell lines. These results suggested a
positive effect of E-cadherin on intraepithelial expansion.
Transfection of T24 and J82 with Full-Length Mouse E-Cad-
herin cDNA. To investigate whether E-cadherin is involved in the
IEE of bladder tumors, we transfected T24 cells with the mouse
E-cadherin gene. Earlier, it was shown that T24 cells express a- and
b-catenin (25). We obtained 19 G418-resistant T24 cell clones, with
membrane-bound E-cadherin expression (Fig. 3A). Clones varied with
regard to their levels of immunohistochemically detected E-cadherin
expression. Expression levels of E-cadherin of nine different T24
transfectants were analyzed by flow cytometry. Clones T24H91, T24
2D41, T24D41, and T24H51 had low to moderate expression levels
(Fig. 4B), whereas the clones T24H311 and T24D1011 had a high
expression level of E-cadherin (Fig. 4C). As a negative control for
E-cadherin expression, we used the clones (T24C12, T24F12, and
T24G12) that were G418 resistant but had no detectable expression
of E-cadherin, either by immunofluorescence, immunoblotting, or
flow cytometry (Fig. 4A). Immunoblotting with the DECMA-1 anti-
body on different cell lysates of T24 clones showed a characteristic
band at Mr 120,000 that was typical of the E-cadherin-positive clones
(Fig. 3B). At the ultrastructural level no difference in the presence of
desmosomes between the nontransfected (E-cadherin-negative) and
transfected, E-cadherin-positive T24 cells was noted (data not shown).
Wound Colonization Assay. The capacity to repair lesions in a
confluent cell culture was monitored for the different clones. Strik-
ingly, untransfected T24 cells and the T24 clones T24C12, T24F12,
and T24G12, with no E-cadherin expression, migrated into the de-
nuded area as single cells (Fig. 5A). SD and the T24 clones with a high
or moderate E-cadherin expression filled up the lesions by moving as
a cohesive sheet (Fig. 5B and Table 2). However, no difference in time
required for the repair of the lesions was seen.
In Vitro Embryonic Chicken Heart Invasion Assay. In vitro
invasion of bladder carcinoma cells was examined after 6 days of
cocultivation with embryonic chicken heart fragments. As a negative
control, we used the E-cadherin-positive SD cell line. Tumor cell
adhesion to chicken heart fragments varied from 100% for
T24D1011 and T24H311 cells to 65% for the T24 cells (Table 2).
Untransfected T24 cells exhibited the strongest invasive capacity.
After successful adhesion, T24 tumor cells infiltrated nearly all em-
bryonic chicken heart fragments (87%). SD cells were unable to
invade the embryonic chicken heart fragments at all. Transfection of
E-cadherin in T24 cells resulted in a significant reduction of invasion
for T24D1011 and T24H311 (Table 2). Both cell lines had a high
expression of E-cadherin. Clones T24H91, with a moderate expres-
sion of E-cadherin, T24C12 and T24G12, with absent E-cadherin
expression, exhibited a moderate to high invasive capacity into the
embryonic chicken heart fragments. These results revealed that the
levels of E-cadherin expression of the transfected T24 clones corre-
sponded with their functionality.
IEE of Transfected T24 Cells. The SD cell line was used as a
positive control, because it had the highest expansion rate of the TCC
cell lines (Fig. 2). Transfection of T24 cells with mouse E-cadherin
Fig. 4. Flow cytometry analysis of E-cadherin expression in: A, native T24 cells and the negative controls T24C12, T24F12, T24G12; B, clones T24D41, T24 2D41, T24H51,
and T24H91; and C, clones T24D1011 and T24H311.
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cDNA stimulated IEE of two independently obtained clones,
T24D1011 and T24H311, both with a high expression of the
E-cadherin protein (Fig. 6). Clones with a moderate/low expression
level of E-cadherin (e.g., T24H91) did not show a significant stim-
ulation of IEE. The implantation (defined by the tumor area on day 1)
of the different T24 transfectants was comparable, indicating that
possible differences in IEE could not be attributed to differences in
attachment of the T24 transfectants to the wounded area. The expres-
sion of integrins was determined by flow cytometry in T24,
T24H311, T24D1011, and T24C12. In the four tested clones, no
differences were observed in expression levels of a1-, a2-, a3-, a4-,
a5-, a6-, b1-, or b3-integrins (data not shown).
Expansion of T24 Clones on Collagen Type IV-coated Cyclo-
pore Membranes in the Absence of Surrounding Urothelium. We
tested whether the observed differences in IEE rate between the tested
T24 clones could be explained by an altered expansion rate (expan-
sion defined as the outgrowth of a sheet of cells) or proliferative
capacity. The expansion of different T24 clones in the absence of
surrounding urothelium was assessed (Fig. 7). These experiments
revealed no differences in the outgrowth or in the [3H]thymidine
incorporation (data not shown) of the various T24 clones. The mod-
erately E-cadherin-expressing T24 2D41 had a lower expansion rate.
DISCUSSION
The IEE assay used here is considered an experimental model
relevant for the study of the mechanisms underlying the in vivo
expansion of carcinoma in situ of the bladder, because in this model,
IEE is the outcome of the balance between the regenerative potential
of normal urothelial cells and the growth of transformed cells. Previ-
ous studies have shown that this in vitro IEE may be influenced by
exposure to growth factors and by culture on substrates composed of
particular extracellular matrix proteins (10, 11). These earlier studies
suggested that modulation of IEE was largely the consequence of the
interaction of these factors with the normal urothelium, rather than a
direct effect on the bladder carcinoma cells. The observed consider-
able variation among the six tested TCC cell lines in their capacity to
expand at the expense of normal urothelium implies that factors
intrinsic to these cell lines also determine the outcome of the cocul-
tivations.
Previously, we have shown that the pattern of infiltration of TCC
cells into the surrounding normal urothelium is determined by E-
cadherin expression (10, 11). E-cadherin-negative TCC cells infiltrate
the normal urothelium as individual cells, whereas tumor cells with a
homogeneous expression of E-cadherin exhibit a sharp demarcation
with the normal urothelium. The 1207 TCC cell line with a hetero-
geneous expression of E-cadherin in vitro also displays the capacity to
infiltrate the normal urothelium as individual cells. Staining of these
cocultivations with a human specific E-cadherin antibody revealed
that the infiltrative single cells of the 1207 cell line had a reduced or
absent expression of E-cadherin as compared with the high homoge-
neous expression of the primary tumor at the implantation site (data
not shown). These results indicate that a reduced or absent expression
of E-cadherin results in infiltration of the surrounding normal urothe-
lium as single cells.
Comparison of the six TCC cell lines revealed that the two consti-
tutively E-cadherin-negative bladder carcinoma cell lines (T24 and
J82) hardly showed any IEE, whereas three of four E-cadherin-
positive cell lines (SD, RT112, and 1207) did. We hypothesized that
a functional E-cadherin-catenin complex is required for effective IEE
of TCC cells. To further test this hypothesis, we established stable
transfectants of T24 cells expressing the full-length mouse E-cadherin
cDNA. Several clones of E-cadherin-expressing T24 cells were ob-
tained. Functionality of the transfected T24 clones was analyzed with
the embryonic chicken heart in vitro invasion assay (12, 26) and a
wound colonization assay (27).
The E-cadherin-negative cell line T24 was generally capable of
invasion into the embryonic chicken heart, whereas only the T24
transfectants with high expression of E-cadherin (T24H311 and
T24D1011) had a significantly reduced invasive capacity, implying
a functional E-cadherin-catenin complex. The T24 clones with a
moderate/low but homogeneous expression of E-cadherin (e.g.,
T24H91) retained part of their invasiveness (Table 2). This observa-
Fig. 5. Wound colonization of transfected T24 cells. The photographs illustrate the
difference in wound-filling capacity between the E-cadherin-negative T24 clone, T24G12
(A) and an E-cadherin-positive clone, T24D1011 (B).
Table 2 In vitro invasion of E-cadherin-transfected T24 cells
Cell line
E-cadherin
expression of
cultured cells
In vitro confronting cultures
Wound
colonizationAdherenta Invasiveb
SD 11 20/23 (87%) 0/20 (0%) Cohesive sheet
T24 2 15/23 (65%) 13/15 (87%) Single cells
T24D1011 11 34/34 (100%) 3/34 (9%) Cohesive sheet
T24H311 11 11/11 (100%) 2/11 (18%) Cohesive sheet
T24H91 1 21/22 (95%) 7/21 (33%) Cohesive sheet
T24G12 2 21/21 (100%) 11/21 (52%) Single cells
T24C12 2 20/21 (95%) 15/20 (75%) Single cells
T24H51 1 11/12 (92%) 3/11 (27%) Cohesive sheet
a Number of adherent/total number of confronted embryonic chicken heart cultures.
b Number of invasive/number of confronted cultures with adherent tumor cells.
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tion is in accordance with those of Vleminckx et al. (12), who
suggested that a threshold expression of E-cadherin has to be reached
to prevent in vitro invasion into the embryonic chicken heart frag-
ments. Similarly, in IEE assays a significant enhanced expansion rate
was only observed for the two T24 clones with high E-cadherin
expression but not for the T24 clones with a moderate or low expres-
sion level, suggesting that the same E-cadherin-mediated mechanism
induces both suppression of in vitro invasion and promotion of IEE.
The enhanced E-cadherin-mediated expansion rate became manifest
only under the cocultivation conditions of IEE. Thus, increased ex-
pression of E-cadherin by transfected T24 cells was neither associated
with an increased expansion rate on collagen type IV-coated mem-
branes nor with an increased proliferative activity or wound repair.
Several reports documented E-cadherin-mediated suppression of cell
motility and inhibition of proliferation (27–29). This discrepancy with
our findings on T24 cells may be explained by the use of fibroblast
cells in these studies rather than epithelial cells. Furthermore, the
motility assays used in these reports (27–29) were based on single cell
assays, whereas our expansion assay (Fig. 7) monitors the outgrowth
of a cohesive sheet of cells.
Recently, Pignatelli (30) speculated on the possibility of a molec-
ular cross-talk between cadherins and integrins in cancer cells. Be-
cause integrins are involved in motility and could be a regulator in
IEE (7), we examined whether E-cadherin expression levels in trans-
fected T24 cells would correlate with expression levels of integrins.
Flow cytometric analysis of a1-, a2-, a3-, a4-, a5-, a6-, b1-, or
b3-integrin expression levels did not point to such a mechanism in
E-cadherin-transfected T24 cells. It could still be argued that E-
cadherins could lead to an altered localization or affinity of integrins
on the cell membrane. Because we did not find any altered migratory
behavior of the transfected T24 cells in our expansion assay in the
absence of surrounding normal urothelium, E-cadherin-integrin cross-
talk in our transfected T24 cells seems an unlikely mechanism for the
observed IEE. We strongly feel that cohesion of transformed T24 cells
is the most important E-cadherin-mediated determinant for IEE.
Our study suggests that E-cadherin is an important molecule for
Fig. 6. IEE of T24 transfectants. Graphs display the area (mm2)
occupied by human bladder tumor cells in peripheral lesions meas-
ured on different time points. Data are expressed as means (n 5 four
or five cultures, with four peripheral lesions each).
Fig. 7. Expansion of T24 clones in the absence of surrounding normal urothelium. Data are expressed as means (n 5 four cultures).
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IEE of TCC in vitro, but it does not prove that this view holds true for
bladder carcinoma in situ. Although a number of studies analyzed
E-cadherin immunoreactivity during different stages of bladder cancer
progression, none reported on the E-cadherin expression in carcinoma
in situ of the bladder in detail (15–17, 31). In a preliminary study, we
stained paraffin sections with carcinoma in situ of 10 patients for
E-cadherin. All of these 10 lesions had a normal, homogeneous,
membranous expression of E-cadherin, confirming our hypothesis on
the contributory role of E-cadherin in the intraepithelial propagation
of bladder carcinomas.
For carcinogenesis in vivo, our observations would imply that on
the one hand, E-cadherin promotes expansion of carcinoma in situ and
on the other hand, opposes invasiveness of the transformed cells.
Generalizing, E-cadherin-mediated cohesiveness may represent a ma-
jor property of transformed clones, allowing carcinoma in situ to
expand at the expense of surrounding normal epithelial cells in vivo.
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